Bryan Haugen, University of Colorado Anschutz Medical Campus (IMAGE)

University of Colorado Anschutz

Bryan Haugen, University of Colorado Anschutz Medical Campus

Caption

Bryan Haugen, MD, and colleagues show that moderate TSH suppression may be enough even in high-risk thyroid cancer.

Credit

University of Colorado Cancer Center

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.